Sign Up to like & get
recommendations!
0
Published in 2018 at "Biotechnology and Bioengineering"
DOI: 10.1002/bit.26775
Abstract: Ansamitocin P‐3 (AP‐3) produced by Actinosynnema pretiosum is an important antitumor agent for cancer treatment, but its market supply suffers from a low production titer. The role of AP‐3 unusual glycolate unit supply on its…
read more here.
Keywords:
production;
pathway engineering;
actinosynnema pretiosum;
substrate feeding ... See more keywords